SGRY Stock Analysis: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$14.70
0.15 (1.03%)
▲
5d:
-2.84%
30d:
+10.65%
90d:
+22.7%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 4.8/10
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SGRY trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SGRY trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.85
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.78
25.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $14.70, which is considered slightly high relative to its 30-day fair value range of $13.39 to $14.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.2) compared to its historical average (25.4). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $14.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGRY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.95 (+23.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $14.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGRY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.95 (+23.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$13.39 -
$14.60
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.4% below Wall St target ($17.95)
Trading Range Analysis
30-Day Trading Range
$13.39 -
$14.60
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.09
Resistance Level
$14.21
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.24
Wall Street Target
$17.95
(+23.4%)
Revenue Growth (YoY)
4.5%
Profit Margin
-2.3%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
22.2 vs 25.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$13.92
(-4%)
2-Year Target
$13.33
(-8%)
3-Year Target
$12.75
(-12%)
3-Yr Target (if PE normalizes)
(PE: 22→25)
$14.56
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.2, Growth: 46.4%)
$45.64
(+214%)
Base:
(SPY PE: 21.8, Growth: 46.4%)
$44.70
(+207%)
Bear:
(PE: 18.5, Growth: 46.4%)
$37.99
(+161%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.2 to 25.4
Stabilization Target:
$16.62
(+14.2%)
PE Expansion Potential:
+14.2%
Share & Embed Analysis
Last updated: June 23, 2026 2:52 PM ET
Data refreshes hourly during market hours. Next update: 3:52 PM
Data refreshes hourly during market hours. Next update: 3:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Doherty
SELL
8867 shares
2026-03-16
Jason Eric Evans
SELL
20400 shares
2026-03-16
Danielle Burkhalter
SELL
3469 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
